Header Logo

JENNIFER LITTON

Concepts (388)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with JENNIFER LITTON's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that JENNIFER LITTON has written about over time.
Pregnancy Complications, Neoplastic, 9 publications between 2009 and 2014, average publication date August 2011. Carcinoma, Ductal, Breast, 11 publications between 2007 and 2020, average publication date June 2012. Cause of Death, 2 publications between 2013 and 2013, average publication date September 2013. Genes, BRCA1, 20 publications between 2009 and 2021, average publication date April 2015. Breast Neoplasms, 115 publications between 2007 and 2024, average publication date August 2015. Receptor, ErbB-2, 22 publications between 2009 and 2021, average publication date August 2015. Genes, BRCA2, 21 publications between 2009 and 2021, average publication date October 2015. Female, 134 publications between 2007 and 2024, average publication date December 2015. Mutation, 28 publications between 2009 and 2021, average publication date February 2016. Genetic Testing, 21 publications between 2009 and 2021, average publication date February 2016. Heterozygote, 4 publications between 2014 and 2019, average publication date June 2016. Neoplastic Syndromes, Hereditary, 5 publications between 2014 and 2020, average publication date August 2016. BRCA2 Protein, 16 publications between 2010 and 2023, average publication date May 2017. Antineoplastic Combined Chemotherapy Protocols, 29 publications between 2008 and 2024, average publication date September 2017. BRCA1 Protein, 19 publications between 2010 and 2023, average publication date January 2018. Neoadjuvant Therapy, 36 publications between 2008 and 2024, average publication date March 2018. Germ-Line Mutation, 20 publications between 2011 and 2023, average publication date January 2019. Poly(ADP-ribose) Polymerase Inhibitors, 14 publications between 2017 and 2023, average publication date February 2020. Phthalazines, 11 publications between 2017 and 2022, average publication date July 2020. Triple Negative Breast Neoplasms, 29 publications between 2014 and 2024, average publication date November 2020.

To see the data from this visualization as text, click here.
LITTON's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (388)
Explore
_
Co-Authors (155)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_